INFLUENCE OF ANTIBODIES AGAINST CTLA-4 AND PD-1 UPON QUANTITIES OF THEIR TARGET RECEPTORS
Inhibitory receptors CTLA-4 and PD-1 (immune checkpoints) play a key role in regulation of immune reactions. They suppress excessive immune response against pathogenic microbes and prevent autoimmune reactions. The immune checkpoints are targets of the modern effective therapy based on human and hum...
Saved in:
Main Authors: | I. O. Chikileva, I. Zh. Shubina, I. V. Samoylenko, A. V. Karaulov, M. V. Kiselevsky |
---|---|
Format: | article |
Language: | RU |
Published: |
SPb RAACI
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/ca1be543ea6845e3bdecf5e1eee5a835 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CTLA-4 blockade in the treatment of colorectal cancer with microsatellite instability
by: Diana Russo, et al.
Published: (2021) -
Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
by: Marc-Oliver Grimm, et al.
Published: (2021) -
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma
by: Virginia Liberini, et al.
Published: (2021) -
Cutaneous Adverse Events of Immune Checkpoint Inhibitors: A Literature Review
by: Zoe Apalla, et al.
Published: (2021) -
Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies
by: Gkiala A, et al.
Published: (2020)